Indications for PROFILNINE:
Prevention and control of bleeding in Hemophilia B.
Dosage Required (IU) = Body Weight (kg) × Desired Factor IX increase × 1 IU/kg. Individualize. Max infusion rate: 10mL/min. Minor to moderate hemorrhage: 20–30% FIX increase every 16–24hrs for 1–2 days (minor) or 2–7 days (moderate) until healing achieved. Major hemorrhage: 30–50% FIX increase every 16–24hrs for 3–10 days; then maintain FIX levels at 20% until healing achieved. Surgery (pre-op): 30–50% FIX increase every 16–24hrs for 7–10 days (increase FIX to 50% immediately prior to dental extractions); maintain FIX levels at 30–50% until healing achieved.
Not for treating Factor VII deficiency. Contains human plasma; monitor for possible infection transmission (eg, viruses, Creutzfeldt-Jakob disease agent). Liver disease, prolonged treatment duration or if undergoing surgery: increased risk of disseminated intravascular coagulation (DIC) and thrombosis. Monitor for development of inhibitors. Latex sensitivity (diluent). Pregnancy (Cat.C).
Coagulation factor complex.
Headache, fever, chills, flushing, nausea, vomiting, tingling, lethargy, urticaria; hypersensitivity reactions, thrombosis, DIC.
To report suspected adverse reactions, contact Grifols at (888) 474-3657.
Single-dose vials—1 (w. diluent, supplies)